EFFICACY OF CLARITHROMYCIN AGAINST MYCOPLASMA-PNEUMONIAE

被引：59

作者：

CASSELL, GH

DRNEC, J

WAITES, KB

PATE, MS

DUFFY, LB

WATSON, HL

MCINTOSH, JC

机构：

[1] ABBOTT LABS, ABBOTT PK, IL 60064 USA

[2] UNIV ALABAMA, DEPT PATHOL, BIRMINGHAM, AL 35294 USA

[3] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35294 USA

来源：

关键词：

D O I：

10.1093/jac/27.suppl_A.47

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：47 / 59

页数：13

共 23 条

[1] CASSELL GH, 1988, REV INFECT DIS, V10, pS391
[2] MYCOPLASMAS AS AGENTS OF HUMAN-DISEASE
CASSELL, GH
COLE, BC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02) : 80 - 89
[3] COMPARATIVE SUSCEPTIBILITY OF MYCOPLASMA-PNEUMONIAE TO ERYTHROMYCIN, CIPROFLOXACIN, AND LOMEFLOXACIN
CASSELL, GH
WAITES, KB
PATE, MS
CANUPP, KC
DUFFY, LB
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (05) : 433 - 435
[4] Cassell GH., 1985, MYCOPLASMAS MYCOPLAS, V4, P65, DOI [10.1016/B978-0-12-078404-2.50010-5, DOI 10.1016/B978-0-12-078404-2.50010-5]
[5] CHOW AW, 1984, ANTIMICROBIAL THERAP
[6] Fernandes P. B., 1987, Antimicrobic Newsletter, V4, P25, DOI 10.1016/0738-1751(87)90002-5
[7] INVITRO AND INVIVO EVALUATION OF A-56268 (TE-031), A NEW MACROLIDE
FERNANDES, PB
BAILER, R
SWANSON, R
HANSON, CW
MCDONALD, E
RAMER, N
HARDY, D
SHIPKOWITZ, N
BOWER, RR
GADE, E
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) : 865 - 873
[8] FURNERI PM, 1987, CHEMIOTERAPIA, V6, P346
[9] FURNERI PM, 1987, CHEMIOTERAPIA, V6, P341
[10] LABORATORY DIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION .3. DETECTION OF IGM ANTIBODIES TO M-PNEUMONIAE BY A MODIFIED INDIRECT HEMAGGLUTINATION TEST
KOK, TW
MARMION, BP
VARKANIS, G
WORSWICK, DA
MARTIN, J
[J]. EPIDEMIOLOGY AND INFECTION, 1989, 103 (03) : 613 - 623